This site is intended for healthcare professionals

Go to /sign-in page

You can view 5 more pages before signing in

Choice of antibiotic in community acquired pneumonia

Last reviewed dd mmm yyyy. Last edited dd mmm yyyy

Authoring team

  • assess severity in adults based on clinical judgement guided by mortality risk score (CRB65 or CURB65):
    • low severity – CRB65 0 or CURB65 0 or 1
    • moderate severity – CRB65 1 or 2 or CURB65 2
    • high severity – CRB65 3 or 4 or CURB65 3 to 5
    • 1 point for each parameter: confusion, (urea >7 mmol/l), respiratory rate >= 30/min, low systolic (<90 mm Hg) or diastolic (<=60 mm Hg) blood pressure, age >= 65
    • assess severity in children based on clinical judgement
    • offer an antibiotic. Start treatment as soon as possible after diagnosis, within 4 hours (within 1 hour if sepsis suspected and person meets any high risk criteria

  • when choosing an antibiotic, take account of severity, risk of complications, local antimicrobial resistance and surveillance data, recent antibiotic use and microbiological results
  • * Stop antibiotics after 5 days unless microbiological results suggest a longer course is needed or the person is not clinically stable.

 

 

 

Reference:


Related pages

Create an account to add page annotations

Annotations allow you to add information to this page that would be handy to have on hand during a consultation. E.g. a website or number. This information will always show when you visit this page.

The content herein is provided for informational purposes and does not replace the need to apply professional clinical judgement when diagnosing or treating any medical condition. A licensed medical practitioner should be consulted for diagnosis and treatment of any and all medical conditions.

Connect

Copyright 2024 Oxbridge Solutions Limited, a subsidiary of OmniaMed Communications Limited. All rights reserved. Any distribution or duplication of the information contained herein is strictly prohibited. Oxbridge Solutions receives funding from advertising but maintains editorial independence.